company background image
MVP logo

Medical Developments International ASX:MVP Rapporto sulle azioni

Ultimo prezzo

AU$0.47

Cap. di mercato

AU$52.9m

7D

3.3%

1Y

-42.7%

Aggiornato

04 Nov, 2024

Dati

Dati finanziari dell'azienda +

Medical Developments International Limited

ASX:MVP Rapporto sulle azioni

Cap. di mercato: AU$52.9m

MVP Panoramica delle azioni

Medical Developments International Limited produce e distribuisce soluzioni mediche di emergenza in Australia, Europa, Stati Uniti e a livello internazionale.

MVP analisi fondamentale
Punteggio fiocco di neve
Valutazione5/6
Crescita futura4/6
Prestazioni passate0/6
Salute finanziaria5/6
Dividendi0/6

Medical Developments International Limited Concorrenti

Storia dei prezzi e prestazioni

Riepilogo dei massimi storici, delle variazioni e dei cali di prezzo di tutti i tempi per Medical Developments International
Prezzi storici delle azioni
Prezzo attuale dell'azioneAU$0.47
Massimo di 52 settimaneAU$1.08
Minimo di 52 settimaneAU$0.38
Beta1.63
1Variazione di 1 mese4.44%
Variazione a 3 mesi20.51%
Variazione di 1 anno-42.68%
3Variazione a 3 anni-90.69%
Variazione a 5 anni-91.68%
Variazione dall'IPO-2.08%

Notizie e aggiornamenti recenti

Recent updates

Positive Sentiment Still Eludes Medical Developments International Limited (ASX:MVP) Following 27% Share Price Slump

May 13
Positive Sentiment Still Eludes Medical Developments International Limited (ASX:MVP) Following 27% Share Price Slump

Is Medical Developments International (ASX:MVP) In A Good Position To Invest In Growth?

May 03
Is Medical Developments International (ASX:MVP) In A Good Position To Invest In Growth?

Why Investors Shouldn't Be Surprised By Medical Developments International Limited's (ASX:MVP) 28% Share Price Plunge

Mar 11
Why Investors Shouldn't Be Surprised By Medical Developments International Limited's (ASX:MVP) 28% Share Price Plunge

Medical Developments International Limited (ASX:MVP) Soars 28% But It's A Story Of Risk Vs Reward

Jan 16
Medical Developments International Limited (ASX:MVP) Soars 28% But It's A Story Of Risk Vs Reward

Will Medical Developments International (ASX:MVP) Spend Its Cash Wisely?

Jan 03
Will Medical Developments International (ASX:MVP) Spend Its Cash Wisely?

Is Medical Developments International (ASX:MVP) In A Good Position To Deliver On Growth Plans?

Aug 09
Is Medical Developments International (ASX:MVP) In A Good Position To Deliver On Growth Plans?

We're Keeping An Eye On Medical Developments International's (ASX:MVP) Cash Burn Rate

Apr 24
We're Keeping An Eye On Medical Developments International's (ASX:MVP) Cash Burn Rate

Is Medical Developments International (ASX:MVP) In A Good Position To Deliver On Growth Plans?

Jul 04
Is Medical Developments International (ASX:MVP) In A Good Position To Deliver On Growth Plans?

Some Analysts Just Cut Their Medical Developments International Limited (ASX:MVP) Estimates

Mar 04
Some Analysts Just Cut Their Medical Developments International Limited (ASX:MVP) Estimates

Medical Developments International Limited (ASX:MVP) Analysts Just Slashed This Year's Estimates

Mar 05
Medical Developments International Limited (ASX:MVP) Analysts Just Slashed This Year's Estimates

If You Had Bought Medical Developments International (ASX:MVP) Shares Five Years Ago You'd Have Earned 56% Returns

Feb 07
If You Had Bought Medical Developments International (ASX:MVP) Shares Five Years Ago You'd Have Earned 56% Returns

Don't Ignore The Fact That This Insider Just Sold Some Shares In Medical Developments International Limited (ASX:MVP)

Dec 16
Don't Ignore The Fact That This Insider Just Sold Some Shares In Medical Developments International Limited (ASX:MVP)

Medical Developments International Limited's (ASX:MVP) Has Been On A Rise But Financial Prospects Look Weak: Is The Stock Overpriced?

Dec 10
Medical Developments International Limited's (ASX:MVP) Has Been On A Rise But Financial Prospects Look Weak: Is The Stock Overpriced?

Rendimenti per gli azionisti

MVPAU PharmaceuticalsAU Mercato
7D3.3%-2.3%-1.1%
1Y-42.7%61.9%16.1%

Ritorno vs Industria: MVP underperformed the Australian Pharmaceuticals industry which returned 61.9% over the past year.

Rendimento vs Mercato: MVP underperformed the Australian Market which returned 16.1% over the past year.

Volatilità dei prezzi

Is MVP's price volatile compared to industry and market?
MVP volatility
MVP Average Weekly Movement7.6%
Pharmaceuticals Industry Average Movement11.9%
Market Average Movement8.6%
10% most volatile stocks in AU Market17.5%
10% least volatile stocks in AU Market3.6%

Prezzo delle azioni stabile: MVP has not had significant price volatility in the past 3 months compared to the Australian market.

Volatilità nel tempo: MVP's weekly volatility (8%) has been stable over the past year.

Informazioni sull'azienda

FondatoI dipendentiAMMINISTRATORE DELEGATOSito web
1972n/aBrent MacGregormedicaldev.com

Medical Developments International Limited produce e distribuisce soluzioni mediche di emergenza in Australia, Europa, Stati Uniti e a livello internazionale. L'azienda opera attraverso i segmenti Gestione del dolore e Respiratorio. L'azienda offre Penthrox, un prodotto antidolorifico per traumi ed emergenze da utilizzare negli ospedali, nei dipartimenti di emergenza, nei servizi di ambulanza, nei farmaci per lo sport e per l'analgesia durante brevi procedure.

Medical Developments International Limited Riepilogo dei fondamenti

Come si confrontano gli utili e i ricavi di Medical Developments International con la sua capitalizzazione di mercato?
MVP statistiche fondamentali
Capitalizzazione di mercatoAU$52.95m
Guadagni(TTM)-AU$40.99m
Ricavi(TTM)AU$33.15m

1.6x

Rapporto P/S

-1.3x

Rapporto P/E

Guadagni e ricavi

Statistiche chiave sulla redditività dall'ultima relazione sugli utili (TTM)
MVP Conto economico (TTM)
RicaviAU$33.15m
Costo del fatturatoAU$8.78m
Profitto lordoAU$24.37m
Altre speseAU$65.36m
Guadagni-AU$40.99m

Ultimi guadagni dichiarati

Jun 30, 2024

Prossima data di guadagno

n/a

Utile per azione (EPS)-0.36
Margine lordo73.50%
Margine di profitto netto-123.66%
Rapporto debito/patrimonio netto0%

Come si è comportato MVP nel lungo periodo?

Vedi performance storica e confronto